Symbols

HYPD

Hyperion DeFi·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About HYPD

Hyperion Defi, Inc.

A clinical stage biopharmaceutical company

Industry

Software

Established Date

03/12/2014

Listing Date

01/25/2018

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.hyperiondefi.com

Security Type

Common stock

Office address

23461 South Point Drive Suite 390 Laguna Hills CA 92653

Business

Introduction

Hyperion DeFi, Inc., was incorporated under the laws of the State of Florida on March 12, 2014. The company is the first company to go public in the United States and has a long-term strategic reserve of Hyperliquid native token HYPE, as well as a pioneering digital ophthalmic technology company. According to information provided by various blockchain data tracking sources including Artemis Analytics and DefiLama, the company is working to provide shareholders with simplified exposure to the Hyperliquit ecosystem, which they consider to be one of the highest revenue blockchains in the world. Meanwhile, the company continued to complete the development and registration of the Optejet ophthalmic liquid delivery device as planned.

Company Financials

EPS

HYPD has released its 2025 Q4 earnings. EPS was reported at -4.94, versus the expected -0.09, missing expectations. The chart below visualizes how HYPD has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

HYPD has released its 2025 Q4 earnings report, with revenue of 496.23K, reflecting a YoY change of 1666.38%, and net profit of -39.77M, showing a YoY change of -99.28%. The Sankey diagram below clearly presents HYPD's revenue sources and cost distribution.